179.01MMarket Cap-5.70P/E (TTM)
17.490High16.000Low106.81KVolume17.140Open16.930Pre Close1.80MTurnover1.43%Turnover RatioLossP/E (Static)10.79MShares24.00052wk High5.23P/B123.88MFloat Cap12.78052wk Low--Dividend TTM7.47MShs Float135.170Historical High--Div YieldTTM8.80%Amplitude7.100Historical Low16.854Avg Price1Lot Size
MediWound Stock Forum
MediWound to Host Virtual Key Opinion Leader Event to Discuss EscharEx® Phase III VALUE Study in Venous Leg Ulcers and Its Commercial Opportunity on January 8, 2025
Tuesday, 17th December at 8:00 am
YAVNE, Israel, Dec. 17, 2024 (GLOBE NEWSWIRE) -- MediWound Ltd. (NASDAQ: MDWD), a global leader in next-generation enzymatic therapeutics for tissue repair, today announced it will host a virtual Key Opinion Leader (KOL) event on Wednesday, January 8, 2025, at 10:00 AM ET. T...
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
No comment yet